Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA
R. Salpini,S. D'Anna,L. Piermatteo,E. Teti,A. Di Lorenzo,G. Brancaccio,G. Torre,V. Malagnino,M. Iannetta,F. Ceccherini-Silberstein,C. Pasquazzi,U. Cillo,A. Vitale,E. Gringeri,M. Magrofuoco,M. Pacenti,L. Baiocchi,S. Francioso,I. Lenci,A.M. Geretti,M.L. Abate,A. Olivero,G.B. Gaeta,L. Sarmati,M. Rizzetto,G.P. Caviglia,V. Svicher
DOI: https://doi.org/10.1016/j.dld.2024.01.045
IF: 5.165
2024-02-01
Digestive and Liver Disease
Abstract:Background & Aims HDV exploits HBV surface glycoproteins (HBsAg) for viral morphogenesis and infectivity. Here, we investigate HBV-HDV replicative activity and their interplay by analysing liver biopsies from chronically HBV/HDV infected (CHD) patients. Method Liver tissue was analysed from 25 HBeAg-negative CHD patients. Intrahepatic covalently-closed circular DNA (cccDNA), pregenomic HBV-RNA (pgRNA) and HDV-RNA were quantified by droplet-digital-PCR (ddPCR). ddPCR assays were set-up to quantify total HBs transcripts and to distinguish those deriving from cccDNA and integrated HBV-DNA (Grudda,2022). Results Patients had high serum HDV-RNA and HBsAg levels (median [IQR]: 6.3[3.8-7.7] logIU/mL and 14,460[5,207-21,118] IU/mL, respectively) and low HBV viremia (serum HBV-DNA detectable in 48% with median [IQR]: 50[34-214] IU/ml). Median (IQR) ALT was 72(52-102) U/L, half of patients had fibrosis score>F5. Median (IQR) intrahepatic HDV-RNA was 787(1-2913) copies/1000cells, positively correlated with serum HDV-RNA (Rho=0.63, P=0.05). Regarding HBV intrahepatic reservoir, median (IQR) cccDNA and pgRNA were 3(0.1-24) and 8(1-147) copies/1000cells, respectively. Despite a limited HBV reservoir, we observed an abundant production of HBs transcripts (median [IQR] total HBsRNAs: 6,028[409-19,137] copies/1000 cells), positively correlated with serum HBsAg (Rho=0.54; P=0.04). Notably, 99% of HBs transcripts derived from integrated HBV-DNA, with a limited contribution of cccDNA transcriptional activity, supporting HBV-DNA integration as the main HBsAg source in HBeAg-negative CHD. Finally, intrahepatic HDV-RNA levels did not differ according to HBV reservoir size (median[IQR]: 787[1-5,495] and 880[1-3,338] copies/1000cells in cccDNA<3 and >3copies/1000cells, p=0.9), while markers of HBV activity were significantly lower in patients with more restricted HBV reservoir (median[IQR]: 1[1-10] vs 147[9-406] copies/1000cells for pgRNA and 0.3[0.2-1] vs 73[7-243] copies/1000cells for cccDNA-derived HBs transcripts in cccDNA<3 vs >3copies/1000cells, p<0.01 for both). Conclusion Pathways sustaining HDV activity act independently from the extent of intrahepatic HBV reservoir and are fueled by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA. These issues are crucial for deciphering mechanisms underlying HDV persistence, that could jeopardise anti-HDV therapeutic strategies success.
gastroenterology & hepatology